Blood pressure

IoT Cloud Platform market is to reach USD 10330 million by 2028 at a CAGR of 18.2% | Valuates Reports

Retrieved on: 
Tuesday, June 14, 2022
Cloud, Oxygen, Software, Seed, Time, Automation, Volume Table of Contents, Humidity, Electronic health record, Temperature, Health care, Congestion, Pressure, Farmer, Wireless ambulatory ECG, Solution, Investment, Global, IOT, Growth, Anomaly, Health, Weather, Efficiency, HVAC, Blood pressure, Smartphone, Laika (EHR testing framework), CAGR, USD, Video game console, Medical imaging

The global IoT Cloud Platform market size is projected to reach USD 10330 million by 2028, from USD 3108.9 million in 2021, at a CAGR of 18.2% during 2022-2028.

Key Points: 
  • The global IoT Cloud Platform market size is projected to reach USD 10330 million by 2028, from USD 3108.9 million in 2021, at a CAGR of 18.2% during 2022-2028.
  • This will boost the growth of the IoT cloud platform market during the forecast period.
  • This will boost the growth of the IoT cloud platform market in the upcoming period.
  • All these factors will boost the growth prospects of the IoT cloud platform market during the forecast period.

Vitalant Declares a Critical Blood Shortage on World Blood Donor Day, Urges Donations

Retrieved on: 
Tuesday, June 14, 2022
World Health Organization, Cholesterol, Science, School, Plasma, World Blood Donor Day, Awareness, Blood, World, Multimedia, Patient, Pulse, Hospital, Twitter, Blood pressure, Instagram, Leukemia, Solidarity, Medical device, Vitalant, Facebook

SCOTTSDALE, Ariz., June 14, 2022 /PRNewswire/ -- Nonprofit blood services provider Vitalant is alerting the public today – World Blood Donor Day – to help reverse a critical blood shortage by making an appointment to give in the coming days and weeks. Donors of all blood types are needed.

Key Points: 
  • SCOTTSDALE,Ariz., June 14, 2022 /PRNewswire/ -- Nonprofit blood services provider Vitalant is alerting the public today World Blood Donor Day to help reverse a critical blood shortage by making an appointment to give in the coming days and weeks.
  • In April and May, Vitalant collected about 13,000 fewer blood donations compared to the year prior.
  • In addition to helping patients, new blood donors can learn their preliminary blood type* during their first visit.
  • Established by the World Health Organization, World Blood Donor Day is recognized each year on June 14 to raise awareness of the need for a safe and readily available blood supply.

Livindi Improves Telemedicine, Remote Patient Monitoring and Video Calling

Retrieved on: 
Monday, June 13, 2022
Managed Care, Health, Telemedicine, Virtual Medicine, Conditional sentence, UnitedHealth Group, Caregiver, Doctor, Hearing, Medicine, Vital signs, Program, Health status of Asian Americans, CEO, UNH, Remote patient monitoring, Patient satisfaction, ER, RPM, Multimedia, Health, Patient, Technology, NYSE, Tablet, Quality of life, Prevalence, Blood pressure, Pharmaceutical industry, Hospital, Medical imaging, Telehealth

The enhanced remote patient monitoring (RPM) includes patient service monitoring, telemedicine virtual appointments and medication adherence.

Key Points: 
  • The enhanced remote patient monitoring (RPM) includes patient service monitoring, telemedicine virtual appointments and medication adherence.
  • A recent study has shown that Remote Patient Monitoring (RPM) can help reduce medication non-adherence in older adults.
  • With the increasing prevalence of chronic diseases such as diabetes and heart disease, remote patient service monitoring is becoming an increasingly important tool for healthcare providers.
  • With Livindis integrated RPM (real-time patient management) module, Telemedicine for Doctors is the perfect tool for ensuring excellent patient care.

Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022

Retrieved on: 
Monday, June 13, 2022
ENDO, People, Lists of diseases, Weight loss, Life expectancy, Diabetes, Motherboard, Drug development, Cancer, Waist, Marketing, III, Human, HKEX, Cardiovascular disease, Trial of the century, Quality of life, Obesity, Population, NDA, Lilly, CMC, Bevacizumab, Overweight, MD Anderson Cancer Center, Social conditions in Honduras, Conditional sentence, Ophthalmology, Eli Lilly and Company, Patient, Control, Incidence, Integrity, Blood pressure, Eli Lilly, Oxyntomodulin, Nature, News, Environment, BMI, Chemistry, Autoimmunity, NMPA, Stock exchange, Mortality, OXM, SAN, Clinical trial, Hospital, Principal, Safety, Pharmaceutical industry, Coffee, Vaccine, Risk management, Company, Incyte, Ramucirumab, Food and Drug Administration Safety and Innovation Act

This randomized, double-blind, placebo-controlled multiple-ascending-dose study (ClinicalTrials.gov, NCT04440345) evaluated the safety, tolerability and PK/PD characteristics of mazdutide in Chinese participants with overweight or obesity.

Key Points: 
  • This randomized, double-blind, placebo-controlled multiple-ascending-dose study (ClinicalTrials.gov, NCT04440345) evaluated the safety, tolerability and PK/PD characteristics of mazdutide in Chinese participants with overweight or obesity.
  • Mazdutide up-titrated to 10 mg and 9 mg showed a similar safety profile with that of low-dose cohorts.
  • Meanwhile, this study further validated the multiple metabolic benefits offered by mazdutide to patients with overweight or obesity.
  • We will continue to develop high-dose mazdutide in overweight or obesity and other potential indications and expect more exciting results."

Almost 1 In Every 4 Adult Male Deaths in the United States is Caused by Heart Disease and African American men account for 100,000 more Cardiovascular Disease Deaths than Caucasian Men

Retrieved on: 
Thursday, June 9, 2022
Metre, Internet, Research, CCM, Degenerative disease, CVD, Cardiovascular disease, DBP, CEO, Population health, PEW, ER, Solution, RPM, Telehealth, Patient, Technology, SBP, Smart meter, Incidence, Diet, Obesity, Industry, Blood pressure, American Heart Association, Smartphone, Death, Medical device, Mobile phone

Heart disease is the number one cause of death among American men1.

Key Points: 
  • Heart disease is the number one cause of death among American men1.
  • Providing at-risk patients with an easy way to track their blood pressure and weight at home is the key to spotting concerning trends early.
  • According to American Heart Association research2, "real-time monitoring programs can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP) significantly, compared to traditional self-monitoring.
  • Recent research from the PEW Institute3 found minorities are almost 20 percent less likely to have access to broadband internet.

Gynov Helps Manage Gestational Diabetes

Retrieved on: 
Thursday, June 9, 2022
Woman, Research, NVP, Nausea, Child, Gestational diabetes, CDC, Female, Insulin resistance, Reproductive health, PCOS, Insulin, Diabetes, Folate, Health, Vomiting, Stillbirth, Pregnancy, Blood pressure, Plasma protein binding, Mayo Clinic, Dietary supplement, Medical device, Pharmaceutical industry, MD, Endometriosis

FORT LAUDERDALE, Fla., June 9, 2022 /PRNewswire/ -- Gynov has spent the last several years conducting exhaustive research on women's health. Much of this has centered on the need for more therapeutic solutions for common conditions, such as PCOS, Endometriosis, and NVP (nausea and vomiting of pregnancy). One area that Gynov has also helped address is the ability to manage gestational diabetes.

Key Points: 
  • One area that Gynov has also helped address is the ability to manage gestational diabetes.
  • Gestational diabetes is a form of diabetes that develops while a woman is pregnant.
  • According to the CDC, up to 10% of pregnancies in the United States alone are impacted by gestational diabetes every year.
  • It provides a clean, naturally-focused, scientifically-backed therapeutic solution that enables women to manage gestational diabetes and provide a healthier journey through pregnancy for both themselves and their children.

Livindi Continues to Expand Award Winning Products to Help Older Adults Stay Safe, Healthy and Happy

Retrieved on: 
Wednesday, June 8, 2022
Seniors, Insurance, Pharmaceutical, General Health, Health, Mental Health, Professional Services, Consumer, Exercise, UnitedHealth Group, Caregiver, Medicine, Telehealth, Behavior, Depression, CEO, UNH, Multimedia, Heart rate, Patient, Pulse, Review, NYSE, Compliance, Thermoregulation, Blood pressure, Communication, Calendar, Mobile phone, Risk management, Residential care

Families, staff at homecare agencies and facilities can now also check medication adherence and start a video call to review compliance.

Key Points: 
  • Families, staff at homecare agencies and facilities can now also check medication adherence and start a video call to review compliance.
  • The personal reminder and group calendar module provides a new way to stay organized with all the important dates in one place!
  • With a regular and varied activity schedule older adults retain a strong sense of independence and stress levels decrease.
  • About Livindi: Livindi is an in-home connected care platform for seniors, caregivers, senior living providers and insurers to communicate, monitor, and deliver care services.

New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.

Retrieved on: 
Wednesday, June 8, 2022
NTT Data, Life, IPhone, Achievement, Natural science, Health status of Asian Americans, Journal, Covenant Transport, Blood pressure, Transdermal optical imaging, Patent, Public sector, Scientific Reports, BMI, TOI, BP, Publication, Android, OSA, Face, JNS, Obstructive sleep apnea, Ministry of Health & Wellness, Daimler, CDL, Frontiers, Industry, Population, Department, Wellness, Family, Smartphone, Department of transportation, Body mass index, Hypertension, Mobile phone, Taxicab, Cigna, Transport, Greyhound, Sanitas, Anura, Psychology, Health

This app, called the CDL Health Scanner, allows drivers to quickly scan key vitals using either an iPhone or Android device.

Key Points: 
  • This app, called the CDL Health Scanner, allows drivers to quickly scan key vitals using either an iPhone or Android device.
  • It would be impossible for Health in Transportation to offer this valuable tool to the transportation sector without the incredible breakthrough that the Anura technology represents.
  • Of course, the CDL Health Scanner app utilizes only a portion of the monitoring capability that NuraLogix is equipped to provide.
  • Known as 'The Trucker Trainer' by professional drivers nationwide, Bob Perry brings a very distinctive perspective to the transportation industry and its over-the-road drivers.

New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.

Retrieved on: 
Wednesday, June 8, 2022
NTT Data, Life, IPhone, Achievement, Natural science, Health status of Asian Americans, Journal, Covenant Transport, Blood pressure, Transdermal optical imaging, Patent, Public sector, Scientific Reports, BMI, TOI, BP, Publication, Android, OSA, Face, JNS, Obstructive sleep apnea, Ministry of Health & Wellness, Daimler, CDL, Frontiers, Industry, Population, Department, Wellness, Family, Smartphone, Department of transportation, Body mass index, Hypertension, Mobile phone, Taxicab, Cigna, Transport, Greyhound, Sanitas, Anura, Psychology, Health

This app, called the CDL Health Scanner, allows drivers to quickly scan key vitals using either an iPhone or Android device.

Key Points: 
  • This app, called the CDL Health Scanner, allows drivers to quickly scan key vitals using either an iPhone or Android device.
  • It would be impossible for Health in Transportation to offer this valuable tool to the transportation sector without the incredible breakthrough that the Anura technology represents.
  • Of course, the CDL Health Scanner app utilizes only a portion of the monitoring capability that NuraLogix is equipped to provide.
  • Known as 'The Trucker Trainer' by professional drivers nationwide, Bob Perry brings a very distinctive perspective to the transportation industry and its over-the-road drivers.

DGAP-News: Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

Retrieved on: 
Wednesday, June 8, 2022
HBM, Company, Plasma, Investment, Lists of publishing companies, Hormone, RA, News, Partnership, Capital, Development, Diagnosis, Andera-ye Olya, Industry, Heart, Aldosterone, MPH, Hypertension, Chronic kidney disease, Series, Partner, Patient, Mitsubishi Tanabe Pharma, Blood pressure, DGAP, CYP11B2, RTW, Therapy, Growth, Board, Pharmaceutical industry, Security (finance), Medical device, Financial services, Doctor of Philosophy

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

Key Points: 
  • Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension
    The issuer is solely responsible for the content of this announcement.
  • Existing investors, including founding investment firm Catalys Pacific, Samsara BioCapital, HBM Healthcare Investments and Adams Street Partners also participated.
  • As part of the Series B financing, Derek DiRocco, Partner, RA Capital Management and Olivier Litzka, PhD, Partner, Andrea Partners will join the Mineralys Board of Directors.
  • The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101.